Metabolic imaging with FDG-PET and time to progression in patients discontinuing immune-checkpoint inhibition for metastatic melanoma

被引：0
|
作者：
Ferdinandus, J. [1 ]
Zaremba, A. [1 ]
Zimmer, L. [1 ]
Umutlu, L. [1 ]
Seifert, R. [1 ]
Barbato, F. [1 ]
Ugurel, S. [1 ]
Chorti, E. [1 ]
Gruewald, V. [1 ]
Herrmann, K. [1 ]
Schadendorf, D. [1 ]
Fendler, W. P. [1 ]
Livingstone, E. [1 ]
机构：
[1] Univ Hosp Essen, Essen, Germany
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2021年 / 48卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-1075
引用
收藏
页码：S377 / S377
页数：1
相关论文
共 50 条
  • [1] Metabolic imaging with FDG-PET and time to progression in patients discontinuing immune-checkpoint inhibition for metastatic melanoma
    Ferdinandus, Justin
    Zaremba, Anne
    Zimmer, Lisa
    Umutlu, Lale
    Seifert, Robert
    Barbato, Francesco
    Ugurel, Selma
    Chorti, Eleftheria
    Gruenwald, Viktor
    Herrmann, Ken
    Schadendorf, Dirk
    Fendler, Wolfgang Peter
    Livingstone, Elisabeth
    CANCER IMAGING, 2022, 22 (01)
  • [2] Metabolic imaging with FDG-PET and time to progression in patients discontinuing immune-checkpoint inhibition for metastatic melanoma
    Justin Ferdinandus
    Anne Zaremba
    Lisa Zimmer
    Lale Umutlu
    Robert Seifert
    Francesco Barbato
    Selma Ugurel
    Eleftheria Chorti
    Viktor Grünwald
    Ken Herrmann
    Dirk Schadendorf
    Wolfgang Peter Fendler
    Elisabeth Livingstone
    Cancer Imaging, 22
  • [3] Additional Benefit of FDG-PET when Discontinuing Immune Checkpoint Inhibitor Therapy in Patients with metastatic Melanoma
    Zaremba, A.
    Ferdinandus, J.
    Zimmer, L.
    Umutlu, L.
    Seifert, R.
    Barbato, F.
    Ugurel, S.
    Chorti, E.
    Gruenwald, V.
    Herrman, K.
    Schadendorf, D.
    Fendler, W. P.
    Livingstone, E.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2021, 19 : 75 - 76
  • [4] Prediction of Early Response to Immune Checkpoint Inhibition Using FDG-PET/CT in Melanoma Patients
    Kudura, Ken
    Dimitriou, Florentia
    Basler, Lucas
    Forster, Robert
    Mihic-Probst, Daniela
    Kutzker, Tim
    Dummer, Reinhard
    Mangana, Joanna
    Burger, Irene A.
    Kreissl, Michael C.
    CANCERS, 2021, 13 (15)
  • [5] Germline genetic association on efficacy of Immune-checkpoint inhibition in Metastatic Melanoma patients
    Ouwerkerk, W.
    Chielie, S.
    Bekkenk, M.
    Van Doorn, R.
    Blank, C. U.
    Haanen, J. B.
    Hospers, G. A.
    Kirchhoff, T.
    Luiten, R.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (12) : S264 - S264
  • [6] Personalizing neoadjuvant immune-checkpoint inhibition in patients with melanoma
    Lucas, Minke W.
    Versluis, Judith M.
    Rozeman, Elisa A.
    Blank, Christian U.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2023, 20 (06) : 408 - 422
  • [7] Personalizing neoadjuvant immune-checkpoint inhibition in patients with melanoma
    Minke W. Lucas
    Judith M. Versluis
    Elisa A. Rozeman
    Christian U. Blank
    Nature Reviews Clinical Oncology, 2023, 20 : 408 - 422
  • [8] Exploration of vascular activation and coagulation in metastatic melanoma patients treated with immune-checkpoint inhibition
    Stadler, J.
    Keller, L.
    Bauer, A. T.
    Mess, C.
    Haberstroh, W.
    Sementsov, M.
    Pantel, K.
    Schneider, S. W.
    Gebhardt, C.
    EXPERIMENTAL DERMATOLOGY, 2021, 30 (03) : E106 - E107
  • [9] Primary resistance to immune-checkpoint inhibitors in patients with metastatic melanoma
    Amaral, Teresa
    Assi, Zeinab
    Keim, Ulrike
    Meiwes, Andreas
    Thomas, Ioannis
    Wilhelmi, Julia
    Eigentler, Thomas
    Garbe, Claus
    Seeber, Olivia
    JOURNAL OF TRANSLATIONAL MEDICINE, 2020, 18
  • [10] Predictive value of FDG-PET imaging for relapse in metastatic melanoma patients treated with immunotherapy
    Mesnard, C.
    Bodet-Milin, C.
    Eugene, T.
    Nguyen, J-M
    Khammari, A.
    Dreno, B.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2020, 34 (10) : 2261 - 2267
12345